SCHEMBL13764790

SCHEMBL13764790

CCO[PH](C)(OCC)OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27678763 0.84
SCHEMBL15389717 0.82
SCHEMBL6438010 0.75
SCHEMBL3138658 0.73 ALDH1A1 (0.35)
SCHEMBL2178952 0.72
Hydrochloric Acid SCHEMBL27506089 0.69
Water SCHEMBL27783959 0.69
SCHEMBL1358796 0.69
SCHEMBL28107572 0.69
Hydrogen Sulfide SCHEMBL27537321 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2780345-B1 COPPER COMPLEXES FOR OPTOELECTRONIC APPLICATIONS CYNORA GMBH (DE) 2017-04-12 EP disclosed
US-8546358-B2 Method of treating asthma JANSSEN PHARMACEUTICA NV (BE) 2013-10-01 US disclosed
US-7563901-B2 Intermediates of 2-substituted carbapenem derivatives and process for production thereof MEIJI SEIKA KAISHA, LTD. (JP) 2009-07-21 US disclosed
US-7429565-B2 Antiviral phosphonate analogs GILEAD SCIENCES, INC. (US) 2008-09-30 US disclosed
US-20080167475-A1 Intermediates of 2-substituted carbapenem derivatives and process for production thereof SASAKI TOSHIRO 2008-07-10 US disclosed